Influenza Vaccines for the Future

From the reviews of the second edition: "What the book delivered was a curious juxtaposition of historical perspective alongside a modern commercial approach: from what went wrong in the swine flu vaccination incident of 1976 in the USA, to which companies are using M2 protein conjugates. ... This type of information is quite hard to glean from the academic literature. It was also great to get solid information about the state of the art today ... . Overall there is some useful detail in this book that is hard to get elsewhere." (Wendy Barclay, Microbiology Today, May, 2011)

• EVOLUTION AND EPIDEMIOLOGY.- Influenza Virus: The Biology of a Changing Virus.- The Epidemiology of Influenza and its Control.- Epidemiology of Influenza in Tropical and Sub-Tropical Low Income Regions.- The Origin and Evolution of H1N1 Pandemic Influenza Viruses.- The Emergence of 2009 H1N1 Pandemic Influenza.- IMMUNITY AND VACCINE STRATEGIES.- Influenza Vaccines have Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic.- Influenza and Influenza Vaccination in Children.- The Immune Response to Influenza A Viruses.- Correlates of Protection Against Influenza.- The Role of Animal Models in Influenza Vaccine Research.- Live Attenuated Influenza Vaccine.- Cell Culture-Derived Influenza Vaccines.- Conserved Internal Proteins as Potential Universal Vaccines.- Adjuvants for Influenza Vaccines: The Role of Oil-in-Water Adjuvants.- Lesson Learned from Clinical Trials in 1976 and 1977 with Vaccines for the Newly Emerged Swine and Russian Influenza A/H1N1 Viruses.- Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza.- ECONOMIC AND SOCIAL IMPLICATIONS.- Learning from the First Pandemic of the 21st Century.- Economic Implications of Influenza and Influenza Vaccine.